The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 4, 2008, Pages 339-348

  Reuben, James M ^a   Krishnamurthy, Savitri ^a   Woodward, Wendy ^a   Cristofanilli, Massimo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Circulating tumor cells; Targeted therapies

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; PACLITAXEL; TRASTUZUMAB;

ADJUVANT THERAPY; ADVANCED CANCER; ANTIGEN BINDING; AUTOMATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL FUNCTION; CELL ISOLATION; CELL SELECTION; CELL SEPARATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DENSITY GRADIENT CENTRIFUGATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MAGNETIC SEPARATION; MASTECTOMY; METASTASIS; MICROFLUOROMETRY; MONOTHERAPY; NUCLEIC ACID ANALYSIS; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; RECURRENT CANCER; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TREATMENT RESPONSE; TUMOR CELL;

EID: 68149130866     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.4.339     Document Type: Review

References (71)